Be sure to get enough of the 'sunshine vitamin' this winter
In the middle of winter when sunshine can be hard to come by, it's tough to get enough vitamin D, but one expert has some advice.
Jan 15, 2024
0
6
In the middle of winter when sunshine can be hard to come by, it's tough to get enough vitamin D, but one expert has some advice.
Jan 15, 2024
0
6
A cross-disciplinary University of Alberta research team has uncovered a biological marker for scleroderma that can predict which patients will develop severe disease and could also lead to new treatments.
Jan 9, 2024
0
1
For children in early childhood, exposure to green space has a positive impact on bone health, according to a study published online Jan. 4 in JAMA Network Open.
Jan 9, 2024
0
0
Acute myeloid leukemia (AML) is a cancer type that originates in the bone marrow. Despite being considered a rare disease, it is the most common type of acute leukemia and progresses rapidly, necessitating immediate treatment.
Jan 5, 2024
0
0
A pair of proteins, YAP and TAZ, has been identified as conductors of bone development in the womb and could provide insight into genetic diseases such as osteogenesis imperfecta, known commonly as "brittle bone disease."
Jan 4, 2024
0
32
Seniors with vision issues are at much higher risk for dangerous falls, new research confirms.
Dec 29, 2023
0
32
Medical investigators are theorizing that a combination of two treatments that activate myeloid cells may effectively treat a recalcitrant form of pancreatic cancer that thwarts conventional immunotherapy.
The cranial bone in the human body performs very important functions, such as protecting the brain and enabling the passage of the cranial nerves that are essential to physiological functioning. Critical-sized cranial defects ...
Dec 22, 2023
0
0
Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant. Their study, published in the Journal of Clinical ...
Dec 21, 2023
0
0
Researchers have found a way to predict which patients are likely to respond to radium-223, a standard treatment for advanced prostate cancer that has spread to the bones.
Dec 21, 2023
0
1